The Patent Finder

Immungene Inc.

Also on record
Records under this name other than the patents Immungene Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 4 of 4 · Back to Immungene Inc.

PatentTitleStatus Expires Confidence
US 9,534,057Methods of treating tumors with engineered antibody-interferon mutant fusion molecules
Lapsed on the fee record
Ended Jan 3, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jan 3, 2025From the USPTO record
US 10,259,854Engineered antibody-interferon mutant fusion molecules
Lapsed on the fee record
Ended Apr 16, 2023 · From the USPTO record
Lapsed on the fee recordEnded Apr 16, 2023From the USPTO record
US 9,783,589Engineered antibody-interferon fusion molecules for treatment of autoimmune diseases
Lapsed on the fee record
Ended Oct 10, 2021 · From the USPTO record
Lapsed on the fee recordEnded Oct 10, 2021From the USPTO record
US 9,534,056Engineered TAA antibody-TNFSF member ligand fusion molecules
Lapsed on the fee record
Ended Jan 3, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jan 3, 2021From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited